来源：https://www.biospace.com/article/releases/fda-accepts-genentech-s-supplemental-new-drug-application-for-xofluza-baloxavir-marboxil-for-the-treatment-of-influenza-in-people-at-high-risk-of-complications/

原标题：《FDA接受抗流感新药XOFLUZA补充新药申请--针对流感并发症高风险人群》